Literature DB >> 31887283

Machine Learning Characterization of COPD Subtypes: Insights From the COPDGene Study.

Peter J Castaldi1, Adel Boueiz2, Jeong Yun2, Raul San Jose Estepar3, James C Ross3, George Washko4, Michael H Cho2, Craig P Hersh2, Gregory L Kinney5, Kendra A Young5, Elizabeth A Regan6, David A Lynch7, Gerald J Criner8, Jennifer G Dy9, Stephen I Rennard10, Richard Casaburi11, Barry J Make6, James Crapo6, Edwin K Silverman2, John E Hokanson5.   

Abstract

COPD is a heterogeneous syndrome. Many COPD subtypes have been proposed, but there is not yet consensus on how many COPD subtypes there are and how they should be defined. The COPD Genetic Epidemiology Study (COPDGene), which has generated 10-year longitudinal chest imaging, spirometry, and molecular data, is a rich resource for relating COPD phenotypes to underlying genetic and molecular mechanisms. In this article, we place COPDGene clustering studies in context with other highly cited COPD clustering studies, and summarize the main COPD subtype findings from COPDGene. First, most manifestations of COPD occur along a continuum, which explains why continuous aspects of COPD or disease axes may be more accurate and reproducible than subtypes identified through clustering methods. Second, continuous COPD-related measures can be used to create subgroups through the use of predictive models to define cut-points, and we review COPDGene research on blood eosinophil count thresholds as a specific example. Third, COPD phenotypes identified or prioritized through machine learning methods have led to novel biological discoveries, including novel emphysema genetic risk variants and systemic inflammatory subtypes of COPD. Fourth, trajectory-based COPD subtyping captures differences in the longitudinal evolution of COPD, addressing a major limitation of clustering analyses that are confounded by disease severity. Ongoing longitudinal characterization of subjects in COPDGene will provide useful insights about the relationship between lung imaging parameters, molecular markers, and COPD progression that will enable the identification of subtypes based on underlying disease processes and distinct patterns of disease progression, with the potential to improve the clinical relevance and reproducibility of COPD subtypes.
Copyright © 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  COPD; emphysema; machine learning

Mesh:

Year:  2019        PMID: 31887283      PMCID: PMC7242638          DOI: 10.1016/j.chest.2019.11.039

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  46 in total

1.  Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts.

Authors:  Peter J Castaldi; Marta Benet; Hans Petersen; Nicholas Rafaels; James Finigan; Matteo Paoletti; H Marike Boezen; Judith M Vonk; Russell Bowler; Massimo Pistolesi; Milo A Puhan; Josep Anto; Els Wauters; Diether Lambrechts; Wim Janssens; Francesca Bigazzi; Gianna Camiciottoli; Michael H Cho; Craig P Hersh; Kathleen Barnes; Stephen Rennard; Meher Preethi Boorgula; Jennifer Dy; Nadia N Hansel; James D Crapo; Yohannes Tesfaigzi; Alvar Agusti; Edwin K Silverman; Judith Garcia-Aymerich
Journal:  Thorax       Date:  2017-06-21       Impact factor: 9.139

2.  Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life.

Authors:  Dinh S Bui; Caroline J Lodge; John A Burgess; Adrian J Lowe; Jennifer Perret; Minh Q Bui; Gayan Bowatte; Lyle Gurrin; David P Johns; Bruce R Thompson; Garun S Hamilton; Peter A Frith; Alan L James; Paul S Thomas; Deborah Jarvis; Cecilie Svanes; Melissa Russell; Stephen C Morrison; Iain Feather; Katrina J Allen; Richard Wood-Baker; John Hopper; Graham G Giles; Michael J Abramson; Eugene H Walters; Melanie C Matheson; Shyamali C Dharmage
Journal:  Lancet Respir Med       Date:  2018-04-05       Impact factor: 30.700

3.  Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease.

Authors:  Peter Lange; Bartolome Celli; Alvar Agustí; Gorm Boje Jensen; Miguel Divo; Rosa Faner; Stefano Guerra; Jacob Louis Marott; Fernando D Martinez; Pablo Martinez-Camblor; Paula Meek; Caroline A Owen; Hans Petersen; Victor Pinto-Plata; Peter Schnohr; Akshay Sood; Joan B Soriano; Yohannes Tesfaigzi; Jørgen Vestbo
Journal:  N Engl J Med       Date:  2015-07-09       Impact factor: 91.245

Review 4.  Clinical Epidemiology of COPD: Insights From 10 Years of the COPDGene Study.

Authors:  Diego J Maselli; Surya P Bhatt; Antonio Anzueto; Russell P Bowler; Dawn L DeMeo; Alejandro A Diaz; Mark T Dransfield; Ashraf Fawzy; Marilyn G Foreman; Nicola A Hanania; Craig P Hersh; Victor Kim; Gregory L Kinney; Nirupama Putcha; Emily S Wan; J Michael Wells; Gloria E Westney; Kendra A Young; Edwin K Silverman; MeiLan K Han; Barry J Make
Journal:  Chest       Date:  2019-05-30       Impact factor: 9.410

5.  Turning subtypes into disease axes to improve prediction of COPD progression.

Authors:  Junxiang Chen; Michael Cho; Edwin K Silverman; John E Hokanson; Greg L Kinney; James D Crapo; Stephen Rennard; Jennifer Dy; Peter Castaldi
Journal:  Thorax       Date:  2019-06-12       Impact factor: 9.139

6.  The emphysematous and bronchial types of chronic airways obstruction. A clinicopathological study of patients in London and Chicago.

Authors:  B Burrows; C M Fletcher; B E Heard; N L Jones; J S Wootliff
Journal:  Lancet       Date:  1966-04-16       Impact factor: 79.321

7.  Cluster analysis in severe emphysema subjects using phenotype and genotype data: an exploratory investigation.

Authors:  Michael H Cho; George R Washko; Thomas J Hoffmann; Gerard J Criner; Eric A Hoffman; Fernando J Martinez; Nan Laird; John J Reilly; Edwin K Silverman
Journal:  Respir Res       Date:  2010-03-16

8.  Distinct quantitative computed tomography emphysema patterns are associated with physiology and function in smokers.

Authors:  Peter J Castaldi; Raúl San José Estépar; Carlos S Mendoza; Craig P Hersh; Nan Laird; James D Crapo; David A Lynch; Edwin K Silverman; George R Washko
Journal:  Am J Respir Crit Care Med       Date:  2013-11-01       Impact factor: 21.405

9.  Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.

Authors:  Lowie E G W Vanfleteren; Martijn A Spruit; Miriam Groenen; Swetlana Gaffron; Vanessa P M van Empel; Piet L B Bruijnzeel; Erica P A Rutten; Jos Op 't Roodt; Emiel F M Wouters; Frits M E Franssen
Journal:  Am J Respir Crit Care Med       Date:  2013-04-01       Impact factor: 21.405

Review 10.  Painting a new picture of personalised medicine for diabetes.

Authors:  Mark I McCarthy
Journal:  Diabetologia       Date:  2017-02-07       Impact factor: 10.122

View more
  11 in total

1.  Artificial Intelligence in COPD: New Venues to Study a Complex Disease.

Authors:  Raúl San José Estépar
Journal:  Barc Respir Netw Rev       Date:  2020 May-Dec

2.  Axes of Prognosis: Identifying Subtypes of COVID-19 Outcomes.

Authors:  Emma Whitfield; Claire Coffey; Huayu Zhang; Ting Shi; Xiaodong Wu; Qiang Li; Honghan Wu
Journal:  AMIA Annu Symp Proc       Date:  2022-02-21

3.  Lung proteomic biomarkers associated with chronic obstructive pulmonary disease.

Authors:  Yu-Hang Zhang; Michael R Hoopmann; Peter J Castaldi; Kirsten A Simonsen; Mukul K Midha; Michael H Cho; Gerard J Criner; Raphael Bueno; Jiangyuan Liu; Robert L Moritz; Edwin K Silverman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-10-20       Impact factor: 5.464

4.  A computed tomography imaging-based subject-specific whole-lung deposition model.

Authors:  Xuan Zhang; Frank Li; Prathish K Rajaraman; Jiwoong Choi; Alejandro P Comellas; Eric A Hoffman; Benjamin M Smith; Ching-Long Lin
Journal:  Eur J Pharm Sci       Date:  2022-07-29       Impact factor: 5.112

Review 5.  Pulmonary Functional Imaging: Part 2-State-of-the-Art Clinical Applications and Opportunities for Improved Patient Care.

Authors:  Warren B Gefter; Kyung Soo Lee; Mark L Schiebler; Grace Parraga; Joon Beom Seo; Yoshiharu Ohno; Hiroto Hatabu
Journal:  Radiology       Date:  2021-04-13       Impact factor: 29.146

6.  Systemic Cytokine Profiles of CD4+ T Lymphocytes Correlate with Clinical Features and Functional Status in Stable COPD.

Authors:  Juliana Souza Uzeloto; Alessandra Choqueta de Toledo-Arruda; Bruna Spolador de Alencar Silva; Marjorie de Assis Golim; Aline Márcia Marques Braz; Fabiano Francisco de Lima; Isis Grigoletto; Ercy Mara Cipulo Ramos
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-11-13

7.  Area under the expiratory flow-volume curve: predicted values by artificial neural networks.

Authors:  Octavian C Ioachimescu; James K Stoller; Francisco Garcia-Rio
Journal:  Sci Rep       Date:  2020-10-06       Impact factor: 4.996

Review 8.  Application of P4 (Predictive, Preventive, Personalized, Participatory) Approach to Occupational Medicine.

Authors:  Paolo Boffetta; Giulia Collatuzzo
Journal:  Med Lav       Date:  2022-02-22       Impact factor: 1.275

Review 9.  Individual trajectory-based care for COPD: getting closer, but not there yet.

Authors:  Nicolas Roche; Philippe Devillier; Patrick Berger; Arnaud Bourdin; Daniel Dusser; Jean-François Muir; Yan Martinat; Philippe Terrioux; Bruno Housset
Journal:  ERJ Open Res       Date:  2021-12-13

Review 10.  Artificial Intelligence and Machine Learning in Chronic Airway Diseases: Focus on Asthma and Chronic Obstructive Pulmonary Disease.

Authors:  Yinhe Feng; Yubin Wang; Chunfang Zeng; Hui Mao
Journal:  Int J Med Sci       Date:  2021-06-01       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.